← Eichor
Condition: Candida Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Candida Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Phase 2 · 1 location(s) · Zagazig University · NCT05291845Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT07130799Comparison of Uncomplicated Candidemia Therapy Duration in Children
NA · 22 location(s) · Arkansas Children's Hospital Research Institute · NCT05763251Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Phase N/A · 1 location(s) · Scynexis, Inc. · NCT05908682Oropharyngeal Candidiasis (OPC) and S-ECC
Phase N/A · 1 location(s) · Temple University · NCT05761197Large Algorithm Setting and Validation Study
Phase N/A · 2 location(s) · Nanopath, Inc · NCT07607470Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis
Phase 3 · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT03580733Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
NA · 10 location(s) · Coologics, Inc · NCT06983041Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT07093203Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence
Phase 2 · 1 location(s) · Sano Chemicals Inc · NCT07521137Candida PCR Diagnosis Strategy in Patients From Intensive Care Units
NA · 1 location(s) · University Hospital, Toulouse · NCT04874441Studies of Disorders With Increased Susceptibility to Fungal Infections
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01222741PTX3-targeted Antifungal Prophylaxis
NA · 9 location(s) · Bochud Pierre-Yves · NCT03828773Nasal Antisepsis for C. Auris Prevention
Phase 4 · 3 location(s) · Mary K Hayden · NCT06282510The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study
NA · 2 location(s) · Guy's and St Thomas' NHS Foundation Trust · NCT05434104Evaluation of Rapid Diagnostic Device for the Detection of Candida Auris
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07253311Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Can
Phase 2/Phase 3 · 7 location(s) · AVVA Pharmaceuticals Ltd. · NCT06835361Invasive Candidiasis in Critical Care
Phase N/A · 2 location(s) · University Hospital Ostrava · NCT06456151Comparative Performance of a Vaginal Yeast Test
Phase N/A · 3 location(s) · Uniformed Services University of the Health Sciences · NCT05079711Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07202598Natural History of Individuals With Immune System Problems That Lead to Fungal Infections
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01386437Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
EARLY_Phase 1 · 1 location(s) · Queen's Medical Center · NCT05753813A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invas
Phase 3 · 144 location(s) · Basilea Pharmaceutica · NCT05421858Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidia
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05398809Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal Candidiasis
NA · 1 location(s) · Bioithas SL · NCT07603895Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections
NA · 1 location(s) · Karo Pharma AB · NCT07234786Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis
NA · 6 location(s) · The Archer-Daniels-Midland Company · NCT06480604Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Phase 3 · 27 location(s) · pH-D Feminine Health LLC · NCT07109869The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms
Phase 3 · 2 location(s) · Maastricht University Medical Center · NCT05367089ECMM Candida Registry - CandiReg
Phase N/A · 1 location(s) · University of Cologne · NCT03450005
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.